Translations:SGLT2 inhibitor/23/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 19:46, 12 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (SGLT2 inhibitor)
{| class="wikitable"
|+ TABLE 2: PHARMACOKINETIC PARAMETERS OF VARIOUS SGLT-2 INHIBITORS
|-
! Name of drug !! Bioavailability !! Protein binding !! tmax (hours) !! t1/2 (hours) !! Cmax !! SGLT2 selectivity over SGLT1
|-
| [[Canagliflozin]] || 65% (300 mg dose) || 99% || 1–2 || 10.6 (100 mg dose); 13.1 (300 mg dose) || 1096 ng/mL (100 mg dose); 3480 ng/mL (300 mg dose) || 250 fold
|-
| [[Dapagliflozin]] || 78% || 91% || 1–1.5 || 12.9 || 79.6 ng/mL (5 mg dose); 165.0 ng/mL (10 mg dose) || 1200 fold
|-
| [[Empagliflozin]] || 90–97% (mice); 89% (dogs); 31% (rats) || 86.20% || 1.5 || 13.2 (10 mg dose); 13.3h (25 mg dose) || 259nmol/L (10 mg dose); 687nmol/L (25 mg dose) || 2500 fold
|-
| [[Ertugliflozin]] || 70-90% || 95% || 0.5-1.5 || 11-17 ||268 ng/mL (15 mg dose) || 2000 fold
|-
| [[Ipragliflozin]] (50 mg) || 90% || 96.30% || 1 || 15–16 (50 mg dose) || 975 ng/mL || 360 fold
|-
| [[Luseogliflozin]] || 35.3% (male rats); 58.2% (female rats); 92.7% (male dogs) || 96.0–96.3% || 0.625±0.354 || 9.24±0.928 || 119±27.0 ng/mL || 1650 fold
|-
TABLE 2: PHARMACOKINETIC PARAMETERS OF VARIOUS SGLT-2 INHIBITORS
Name of drug Bioavailability Protein binding tmax (hours) t1/2 (hours) Cmax SGLT2 selectivity over SGLT1
Canagliflozin 65% (300 mg dose) 99% 1–2 10.6 (100 mg dose); 13.1 (300 mg dose) 1096 ng/mL (100 mg dose); 3480 ng/mL (300 mg dose) 250 fold
Dapagliflozin 78% 91% 1–1.5 12.9 79.6 ng/mL (5 mg dose); 165.0 ng/mL (10 mg dose) 1200 fold
Empagliflozin 90–97% (mice); 89% (dogs); 31% (rats) 86.20% 1.5 13.2 (10 mg dose); 13.3h (25 mg dose) 259nmol/L (10 mg dose); 687nmol/L (25 mg dose) 2500 fold
Ertugliflozin 70-90% 95% 0.5-1.5 11-17 268 ng/mL (15 mg dose) 2000 fold
Ipragliflozin (50 mg) 90% 96.30% 1 15–16 (50 mg dose) 975 ng/mL 360 fold
Luseogliflozin 35.3% (male rats); 58.2% (female rats); 92.7% (male dogs) 96.0–96.3% 0.625±0.354 9.24±0.928 119±27.0 ng/mL 1650 fold
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/23/en&oldid=113852"